South Korea Laboratory Chemicals Market

South Korea Laboratory Chemicals Market Size

As per the survey report on South Korea laboratory chemicals market, the market is expected to foresee a CAGR value of 4.4% during 2026-2036, and further generate a market size of USD 152.6 million by the end of 2036. In 2025, the market size was value at USD 92.7 million revenue.

• The South Korea laboratory chemicals market’s growth is driven by expansion of pharmaceutical sector.
• KDMI analyst’s growth analysis foresees volatility in raw material prices as restraint for South Korea laboratory chemicals market.
• In the South Korea laboratory chemicals market, application segment is playing significant role.

South Korea Laboratory Chemicals Market Analysis

Laboratory chemicals are substances used in laboratories for research and experimental purposes such as analysis, synthesis, or for the experiment. They are essential to form the basics of chemistry, biology, physics, and environmental science. Some common chemicals used in laboratories are acetic acid glacial, barium sulphate, carbon disulphide, copper sulphate, potassium bromide, and more. The South Korea laboratory chemicals market growth is driven by increasing demand for high-purity chemicals in pharmaceuticals, biotechnology, and environmental testing. According to a news report, South Korea’s pharmaceutical industry production was valued at 30.639 trillion won in 2025, accounting for an increase of 7.3% from 32.863 trillion won. Therefore, increasing production of pharmaceuticals is leading to increased consumption of laboratory chemicals used for drug discovery, formulation, and testing, thereby contributing to the market growth.

South Korea Laboratory Chemicals Market Growth Drivers and Restraints

Growth Drivers

• Expansion of the pharmaceutical sector – The rapid expansion of South Korea’s pharmaceutical and biopharmaceutical industry is significantly driving demand for laboratory chemicals used in drug development, formulations, quality control, and testing. Leading pharmaceutical companies are investing in the development of biologics, biosimilars, vaccines, and advanced therapeutics. Korea’s chemical industry accounted for 14.3% of the country’s manufacturing production and 17% of Korea’s export. Pharmaceuticals category holds the highest imports worth USD 2.01 billion in 2022 from the U.S. Therefore, the rapid growing of South Korea’s capability of domestic drug manufacturing and increasing pharmaceutical exports is further accelerating the need for high-purity laboratory chemicals. Moreover, growing collaborations between pharmaceutical manufacturers and research institutes creates strong demand for laboratory chemicals across South Korea.
• Increasing research and development activities – Another significant factor driving adoption of advanced laboratory chemicals market is rising investments in research and development across South Korea’s healthcare, biotechnology, chemical, and academic sectors. The R&D investments in Korea’s pharmaceutical industry are expanding due to growth of the pipeline of new drugs. The domestic drug R&D pipeline was recorded at 3,233 in 2024, up from 1,477 in 2020, representing around 14% of the global share. Additionally, government initiatives aimed at promoting innovation and technological advancements are further encouraging establishment of advanced research laboratories in the nation. Also, the growth of domestic biopharmaceutical industry by 5.3% year-on-year worth USD 23 billion, and ranking 13th in the world is accelerating adoption of advanced chemicals for innovative drug development, formulations, and testing procedures.

Restraints

• Volatility in raw material prices – One of the significant restraints is highly dependent laboratory chemicals in raw materials like petrochemical derivatives and specialty raw materials. These materials face high price fluctuation, making it difficult for manufacturers pricing strategy, which can increase production costs. This challenge can restrict manufacturers from adopting advanced laboratory chemicals and rely on conventional methods.
• Competition from alternative technologies – Advancements in automated analytical tools, digital testing platforms, and micro-scale testing technologies are reducing manufacturers reliance on laboratory chemicals. This increase adoption of advanced technologies that are designed to minimize reagent usage, thereby limiting market expansion.

South Korea Laboratory Chemicals Market Segmentation

Our experts at KD Market Insights have segmented the South Korea laboratory chemicals market research report as:

Analyst’s Observation on South Korea Laboratory Chemicals Market Recent Developments

Over the years, the experts at KD Market Insights have been observing the recent developments associated with South Korea laboratory chemicals market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

Ecolab is expanding its global life sciences ambitions with the launch of its first Asian bioprocessing facility, opening a new Bioprocessing Applications Lab (BPAL) in Dongtan, South Korea. The expansion is aimed to support the fast-growing biopharmaceutical sector across Asia, particularly in advanced manufacturing markets like South Korea.

Biesterfeld has acquired a majority stake in South Korean specialty chemicals distributor OSP, marking a strategic expansion into Asia’s high-tech materials market. Biesterfeld said the move strengthens its footprint in industrial applications where technical precision and customer-specific material solutions are increasingly critical.

South Korea Laboratory Chemicals Market Competitive Landscape

Some of the significant participants who top the South Korea laboratory chemicals market growth:

• Thermo Fisher Scientific
• Merck KGaA
• Sigma-Aldrich
• Fisher Scientific
• VWR International
• Agilent Technologies
• Avantor
• PerkinElmer
• SABIC